News Articles Tagged: Necrosis Induction

PNC-27: A New Generation of Peptide Therapeutics for Cancer

Learn about PNC-27, a novel synthetic peptide that targets cancer cell membranes for necrosis, offering a p53-independent approach to cancer treatment.

The Science Behind Solamargine: Mechanism of Action in Cancer Cells

Delve into the scientific details of how Solamargine impacts cancer cells, focusing on its selective necrosis induction and its role in cellular death pathways.

PNC-27: A New Era in Targeted Cancer Therapeutics

Discover how PNC-27, a synthetic anti-cancer peptide, is paving the way for more effective and safer cancer treatments through selective cell membrane targeting and necrosis induction.